IP Library › Assignment 057292/0401
Patent Assignment
Reel/Frame 057292/0401

Merger

Recorded: 2021-05-15 Pages: 8
Assignor
OSTEROS BIOMEDICA LTD.
Executed: 2021-01-25
Assignee
MAXWELL BIOTECH GROUP LTD.
12/19 VERKHNYAYA RADISHCHEVSKAYA STREET, MOSCOW, 109240, RUSSIAN FEDERATION
Covered Properties (2)
Stable Dosage Form of Etidronate-Cytarabine Conjugate, and Use Thereof
Application: 15/780,384 →
Publication: US 2019/0038559
Pharmaceutical Preparation Treating Bone Lesions Caused by Malignant Neoplasms
Application: 16/318,852 →
Publication: US 2019/0240245
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 21, 2018
From: IVANOVA, EKATERINA ALEKSEEVNA; KARPEISKY, ALEXANDER; ZINNEN, SHAWN P.; CARALLI, LISA LYNN
To: OSTEROS BIOMEDICA LTD.
Reel/Frame 047479/0550 →
Assignment of Assignor's Interest Jan 23, 2019
From: IVANOVA, EKATERINA ALEKSEEVNA; KARPEISKY, ALEXANDER; ZINNEN, SHAWN P.; CARALLI, LISA LYNN
To: OSTEROS BIOMEDICA LTD.
Reel/Frame 048106/0976 →